Calidi Biotherapeutics, Inc. (CLDI)

USD 1.44

(-16.76%)

Eps Summary of Calidi Biotherapeutics, Inc.

  • Calidi Biotherapeutics, Inc.'s latest annual eps in 2023 was -1.73 USD , up 42.14% from previous year.
  • Calidi Biotherapeutics, Inc.'s latest quarterly eps in 2024 Q2 was -1.08 USD , up 31.03% from previous quarter.
  • Calidi Biotherapeutics, Inc. reported an annual eps of -29.90 USD in 2022, down -2633.9% from previous year.
  • Calidi Biotherapeutics, Inc. reported an annual eps of 1.18 USD in 2021, up 636.36% from previous year.
  • Calidi Biotherapeutics, Inc. reported a quarterly eps of -2.03 USD for 2024 Q1, down -103.0% from previous quarter.
  • Calidi Biotherapeutics, Inc. reported a quarterly eps of -1.00 USD for 2023 Q4, up 29.08% from previous quarter.

Annual Eps Chart of Calidi Biotherapeutics, Inc. (2023 - 2020)

Historical Annual Eps of Calidi Biotherapeutics, Inc. (2023 - 2020)

Year Eps Eps Growth
2023 -1.73 USD 42.14%
2022 -29.90 USD -2633.9%
2021 1.18 USD 636.36%
2020 -0.22 USD 0.0%

Peer Eps Comparison of Calidi Biotherapeutics, Inc.

Name Eps Eps Difference
AIM ImmunoTech Inc. -0.60 USD -188.333%
Ampio Pharmaceuticals, Inc. -10.67 USD 83.786%
Armata Pharmaceuticals, Inc. -1.91 USD 9.424%
Actinium Pharmaceuticals, Inc. -1.83 USD 5.464%
Azitra, Inc. -54.76 USD 96.841%
Can-Fite BioPharma Ltd. -1.79 USD 3.352%
Chromocell Therapeutics Corporation -1.28 USD -35.156%
CEL-SCI Corporation -0.73 USD -136.986%
iBio, Inc. -6.50 USD 73.385%
Lineage Cell Therapeutics, Inc. -0.12 USD -1341.667%
MAIA Biotechnology, Inc. -1.49 USD -16.107%
Matinas BioPharma Holdings, Inc. -5.28 USD 67.235%
Navidea Biopharmaceuticals, Inc. -0.59 USD -193.22%
NovaBay Pharmaceuticals, Inc. -138.65 USD 98.752%
NanoViricides, Inc. -0.70 USD -147.143%
Oragenics, Inc. -9.18 USD 81.155%
BiomX Inc. -5.10 USD 66.078%
BiomX Inc. -5.10 USD 66.078%
Protalix BioTherapeutics, Inc. 0.12 USD 1541.667%
Palatin Technologies, Inc. -2.02 USD 14.356%
Scorpius Holdings, Inc. -347.20 USD 99.502%